Drugs & therapies

Franchises, drug classes and modalities in the news, ranked by stories in the last 30 days.

Drug / therapy	Company	Stories · 30d	Latest headline
CAR-T & cell therapy	class-wide	8	Ligand, AvenCell ink financing deal worth up to $47M for CAR-T therapies
Vaccines & mRNA	class-wide	7	FDA Nominee Voices Support for Vaccines at Senate Hearing Scrutinizing Trump's Moves
GLP-1 & obesity drugs	class-wide	6	FDA slams GLP-1 compounder over risk of contaminating drugs ‘with filth’
Gene therapy & editing	class-wide	6	Crispr Therapeutics: Why AI Giant Anthropic's Discovery Has Rocked Gene Editing
Alzheimer's drugs	class-wide	4	Acadia falls after mid-stage trial setback for Alzheimer’s psychosis therapy
Drug pricing	class-wide	2	Nurse Spreads Vaccine Misinfo; MD vs PBM; Growing Pains or Red Flags?
Antibody-drug conjugates	class-wide	1	Daiichi Sankyo expands Turbine collaboration to accelerate ADC discovery
Keytruda	Merck & Co. (MSD)	0
Biosimilars & generics	class-wide	0
Dupixent	Sanofi	0